LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

BET INHIBITOR RG6146, VENETOCLAX, AND RITUXIMAB IS A HIGHLY ACTIVE REGIMEN IN RELAPSED/REFRACTORY (R/R) DLBCL: INITIAL REPORT OF PHASE 1B SAFETY, BIOMARKER, AND RESPONSE DATA

Photo by victor_g from unsplash

sultant Advisory Role: Acerta Pharma, Bayer, Celgene, Gilead Sciences, Janssen, Novartis, Roche, and Sandoz; Honoraria: Bayer, Celgene, Gilead Sciences, Janssen, and Roche; Research Funding: Celgene, Janssen, Mundipharma, and Roche; Other… Click to show full abstract

sultant Advisory Role: Acerta Pharma, Bayer, Celgene, Gilead Sciences, Janssen, Novartis, Roche, and Sandoz; Honoraria: Bayer, Celgene, Gilead Sciences, Janssen, and Roche; Research Funding: Celgene, Janssen, Mundipharma, and Roche; Other Remuneration: Travel, accommodations and expenses from Celgene, Janssen, Roche, and Takeda. Zinzani, P: Consultant Advisory Role: Verastem, BMS, MSD, Johnson & Johnson, Servier, and Gilead; Honoraria: Verastem, BMS, MSD, Johnson & Johnson, Servier, and Gilead; Other Remuneration: Fees for participation in a speakers’ bureau from Verastem, BMS, MSD, Johnson & Johnson, Servier, and Gilead. Dirnberger-Hertweck, M: Employment Leadership Position: MorphoSys. Weirather, J: Employment Leadership Position: MorphoSys. Ambarkhane, S: Employment Leadership Position: MorphoSys. Maddocks, K: Consultant Advisory Role: AstraZeneca, Pharmacyclics, Bayer, Teva and Sandoz; Honoraria: AstraZeneca, Pharmacyclics, Bayer, Sandoz and Teva; Research Funding: Pharmacyclics, BMS, Novartis and Merck.

Keywords: roche; verastem bms; msd johnson; bms msd; johnson; advisory role

Journal Title: Hematological Oncology
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.